NKX2-2 and lung cancer: Previously published data demonstrated that KRAS-driven lung cancer cells occasionally suppress expression of NK2 homeobox 2 (NKX2.1), a master-regulatory transcription factor required for normal lung development (Moisés et al., 2017).